We are live on
!
Find out more
VF
Virtu Financial Portfolio holdings
AUM
$3.18B
Turnover
77.45%
1-Year Est. Return
65.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
+$1.3B
(+180%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
62.76%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,160
Increased
164
Reduced
123
Closed
87
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$40.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$21M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$19.2M |
| 4 |
AF
Astoria Financial Corporation
AF
|
+$18.7M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$18.6M |
| 3 |
OKS
Oneok Partners LP
OKS
|
+$15.5M |
| 4 |
ProShares Short S&P500
SH
|
+$9.57M |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$7.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.39% |
| 2 | Financials | 7.24% |
| 3 | Consumer Discretionary | 7% |
| 4 | Healthcare | 6.56% |
| 5 | Technology | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2201
Usio Inc
USIO
$80.4M
| $59K | ﹤0.01% |
+36,454
| New | +$55.4K |
2017 Q3
0 quarters
|
|
|
CORV
2202
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $59K | ﹤0.01% |
+27,658
| New | +$94.1K |
2017 Q3
0 quarters
|
|
2203
Cardiff Oncology
CRDF
$70.1M
| $58K | ﹤0.01% |
+1,098
| New | +$68.5K |
2017 Q3
0 quarters
|
|
2204
Aethlon Medical
AEMD
$3.66M
| $57K | ﹤0.01% |
+1
| New | +$108K |
2017 Q3
0 quarters
|
|
2205
Nomura Holdings
NMR
$27B
| $57K | ﹤0.01% |
+10,301
| New | +$59K |
2017 Q3
0 quarters
|
|
2206
Tonix Pharmaceuticals
TNXP
$104M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
|
XCO
2207
DELISTED
Exco Resources
XCO
| $56K | ﹤0.01% |
+41,928
| New | +$70.7K |
2017 Q3
0 quarters
|
|
2208
Ballard Power Systems
BLDP
$551M
| $55K | ﹤0.01% |
+11,826
| New | +$39K |
2017 Q3
0 quarters
|
|
2209
MBody AI Ltd. Ordinary Share
MBAI
$42.1M
| $55K | ﹤0.01% |
+18
| New | +$54.7K |
2017 Q3
0 quarters
|
|
2210
DHI Group
DHX
$211M
| $55K | ﹤0.01% |
+21,022
| New | +$48K |
2017 Q3
0 quarters
|
|
2211
Traws Pharma
TRAW
$5.68M
| $55K | ﹤0.01% |
+6
| New | +$62.1K |
2017 Q3
0 quarters
|
|
|
ERN
2212
DELISTED
Erin Energy Corp
ERN
| $54K | ﹤0.01% |
+19,752
| New | +$44.9K |
2017 Q3
0 quarters
|
|
|
CTIC
2213
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $54K | ﹤0.01% |
+16,838
| New | +$56.2K |
2017 Q3
0 quarters
|
|
2214
DELISTED
Adverum Biotechnologies
ADVM
| $53K | ﹤0.01% |
+1,458
| New | +$40.5K |
2017 Q3
0 quarters
|
|
2215
Harmonic Inc
HLIT
$1.17B
| $53K | ﹤0.01% |
+17,346
| New | +$64.4K |
2017 Q3
0 quarters
|
|
2216
INVE Technologies, Inc. Common Stock
INVE
$53.8M
| $53K | ﹤0.01% |
+11,365
| New | +$57K |
2017 Q3
0 quarters
|
|
2217
Zevra Therapeutics
ZVRA
$590M
| $53K | ﹤0.01% |
+903
| New | +$48.1K |
2017 Q3
0 quarters
|
|
2218
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $52K | ﹤0.01% |
+838
| New | +$54.2K |
2017 Q3
0 quarters
|
|
2219
CorMedix
CRMD
$566M
| $52K | ﹤0.01% |
+20,028
| New | +$41.5K |
2017 Q3
0 quarters
|
|
|
PME
2220
DELISTED
Pingtan Marine Enterprise Ltd.
PME
| $52K | ﹤0.01% |
+18,004
| New | +$65.8K |
2017 Q3
0 quarters
|
|
|
HGT
2221
DELISTED
Hugoton Royalty Trust
HGT
| $51K | ﹤0.01% |
+27,363
| New | +$48.6K |
2017 Q3
0 quarters
|
|
2222
DELISTED
Real Industry, Inc.
RELY
| $51K | ﹤0.01% |
+28,409
| New | +$60.5K |
2017 Q3
0 quarters
|
|
2223
Abundia Global Impact Group
AGIG
$36.6M
| $50K | ﹤0.01% |
+803
| New | +$55.9K |
2017 Q3
0 quarters
|
|
2224
Professional Diversity Network
IPDN
$1.77M
| $50K | ﹤0.01% |
+22
| New | +$68.5K |
2017 Q3
0 quarters
|
|
|
MIN
2225
Aberdeen Intermediate Income Fund
MIN
$269M
| $50K | ﹤0.01% |
+1,965
| New | +$50.7K |
2017 Q3
0 quarters
|
|
Similar funds
GM
TA
CI
GIA
NSLI
Virtu Financial's Q3 2017 Portfolio in Review
As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,160 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 79% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.
- Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
- Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
- Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
- Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
- Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
- Virtu Financial opened 2,160 new positions and closed 87 in Q3 2017.
- Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.
Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.